FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366990038> ?p ?o ?g. }

• W4366990038 endingPage "350" @default.
• W4366990038 startingPage "341" @default.
• W4366990038 abstract "An important element of precision medicine is the ability to identify, for a specific therapy, those patients for whom benefits of that therapy meaningfully exceed the risks. To achieve this goal, treatment effect usually is examined across subgroups defined by a variety of factors, including demographic, clinical, or pathologic characteristics or by molecular attributes of patients or their disease. Frequently such subgroups are defined by the measurement of biomarkers. Even though such examination is necessary when pursuing this goal, the evaluation of treatment effect across a variety of subgroups is statistically fraught due to both the danger of inflated false-positive error rate from multiple testing and the inherent insensitivity to how treatment effects differ across subgroups. Pre-specification of subgroup analyses with appropriate control of false-positive (i.e. type I) error is recommended when possible. However, when subgroups are specified by biomarkers, which could be measured by different assays and might lack established interpretation criteria, such as cut-offs, it might not be possible to fully specify those subgroups at the time a new therapy is ready for definitive evaluation in a Phase 3 trial. In these situations, further refinement and evaluation of treatment effect in biomarker-defined subgroups might have to take place within the trial. A common scenario is that evidence suggests that treatment effect is a monotone function of a biomarker value, but optimal cut-offs for therapy decisions are not known. In this setting, hierarchical testing strategies are widely used, where testing is first conducted in a particular biomarker-positive subgroup and then is conducted in the expanded pool of biomarker-positive and biomarker-negative patients, with control for multiple testing. A serious limitation of this approach is the logical inconsistency of excluding the biomarker-negatives when evaluating effects in the biomarker-positives, yet allowing the biomarker-positives to drive the assessment of whether a conclusion of benefit could be extrapolated to the biomarker-negative subgroup. Examples from oncology and cardiology are described to illustrate the challenges and pitfalls. Recommendations are provided for statistically valid and logically consistent subgroup testing in these scenarios as alternatives to reliance on hierarchical testing alone, and approaches for exploratory assessment of continuous biomarkers as treatment effect modifiers are discussed." @default.
• W4366990038 created "2023-04-27" @default.
• W4366990038 creator A5040419960 @default.
• W4366990038 creator A5043365013 @default.
• W4366990038 creator A5089221698 @default.
• W4366990038 date "2023-04-24" @default.
• W4366990038 modified "2023-10-14" @default.
• W4366990038 title "Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek" @default.
• W4366990038 cites W1965192399 @default.
• W4366990038 cites W1971061361 @default.
• W4366990038 cites W1974333176 @default.
• W4366990038 cites W1988275593 @default.
• W4366990038 cites W1999550436 @default.
• W4366990038 cites W2003073513 @default.
• W4366990038 cites W2022003731 @default.
• W4366990038 cites W2108284772 @default.
• W4366990038 cites W2121863992 @default.
• W4366990038 cites W2124017538 @default.
• W4366990038 cites W2144535237 @default.
• W4366990038 cites W2154079699 @default.
• W4366990038 cites W2338261571 @default.
• W4366990038 cites W2515805960 @default.
• W4366990038 cites W2567289819 @default.
• W4366990038 cites W2909679049 @default.
• W4366990038 cites W3013239365 @default.
• W4366990038 cites W3083986479 @default.
• W4366990038 cites W3131681136 @default.
• W4366990038 cites W3171517418 @default.
• W4366990038 cites W3184119132 @default.
• W4366990038 cites W3190879912 @default.
• W4366990038 cites W3203258105 @default.
• W4366990038 cites W3209020026 @default.
• W4366990038 cites W4205309211 @default.
• W4366990038 cites W4205350350 @default.
• W4366990038 cites W4225278613 @default.
• W4366990038 cites W4225985995 @default.
• W4366990038 cites W4229626909 @default.
• W4366990038 cites W4285007047 @default.
• W4366990038 doi "https://doi.org/10.1177/17407745231169692" @default.
• W4366990038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37095696" @default.
• W4366990038 hasPublicationYear "2023" @default.
• W4366990038 type Work @default.
• W4366990038 citedByCount "0" @default.
• W4366990038 crossrefType "journal-article" @default.
• W4366990038 hasAuthorship W4366990038A5040419960 @default.
• W4366990038 hasAuthorship W4366990038A5043365013 @default.
• W4366990038 hasAuthorship W4366990038A5089221698 @default.
• W4366990038 hasConcept C126322002 @default.
• W4366990038 hasConcept C143998085 @default.
• W4366990038 hasConcept C177713679 @default.
• W4366990038 hasConcept C185592680 @default.
• W4366990038 hasConcept C2781197716 @default.
• W4366990038 hasConcept C535046627 @default.
• W4366990038 hasConcept C55493867 @default.
• W4366990038 hasConcept C71924100 @default.
• W4366990038 hasConceptScore W4366990038C126322002 @default.
• W4366990038 hasConceptScore W4366990038C143998085 @default.
• W4366990038 hasConceptScore W4366990038C177713679 @default.
• W4366990038 hasConceptScore W4366990038C185592680 @default.
• W4366990038 hasConceptScore W4366990038C2781197716 @default.
• W4366990038 hasConceptScore W4366990038C535046627 @default.
• W4366990038 hasConceptScore W4366990038C55493867 @default.
• W4366990038 hasConceptScore W4366990038C71924100 @default.
• W4366990038 hasFunder F4320337355 @default.
• W4366990038 hasIssue "4" @default.
• W4366990038 hasLocation W43669900381 @default.
• W4366990038 hasLocation W43669900382 @default.
• W4366990038 hasOpenAccess W4366990038 @default.
• W4366990038 hasPrimaryLocation W43669900381 @default.
• W4366990038 hasRelatedWork W1977867207 @default.
• W4366990038 hasRelatedWork W1985876343 @default.
• W4366990038 hasRelatedWork W2032098698 @default.
• W4366990038 hasRelatedWork W2052303540 @default.
• W4366990038 hasRelatedWork W2082183054 @default.
• W4366990038 hasRelatedWork W2085862598 @default.
• W4366990038 hasRelatedWork W2114281628 @default.
• W4366990038 hasRelatedWork W2566747388 @default.
• W4366990038 hasRelatedWork W2971623491 @default.
• W4366990038 hasRelatedWork W4286447573 @default.
• W4366990038 hasVolume "20" @default.
• W4366990038 isParatext "false" @default.
• W4366990038 isRetracted "false" @default.
• W4366990038 workType "article" @default.